Abstract
Type 2 diabetes mellitus (a disease normally appears in the post 40 age group people) now seems to emerging in young adults at the level of global epidemic driven by the increasing burden of obesity. Evidence is accumulating to suggest that this young diabetic cohort is an aggressive phenotype which leads to the premature development of complications that not only have impact on the quality of life but also unfavourably influence the long term outcome, raising the possibility of a serious public health challenge in the next few decades. This chapter reviews the current understanding of the phenomenon of T2DM in the young adults and discusses the clinical challenges in managing this high risk group.
Keywords
- Insulin Resistance
- Acanthosis Nigricans
- Cardiovascular Risk Profile
- Poor Glycaemic Control
- Monogenic Diabetes
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
National Institute for health and clinical Excellence. type 2 diabetes. the management of type 2 diabetes. NICE clinical guideline. London: NICE, 2008.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes res Clin Pract 2010; 87:4–14.
American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes care2000; 23:381–389.
Kitagawa T, Owada M, Urakami T et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr 1998; 37:111–116.
Ogawa Y, Uchigata Y, Otani T et al. Proportion of diabetes type in early-onset diabetes in Japan. Diabetes Care 2007; 30:E30.
Braun B, Zimmermann MB, Kretchmer N et al. Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care 1996; 19:472–479.
Dabelea D, Hanson RL, Bennett PH et al. Increasing prevalence of type II diabetes in American Indian children. Diabetologia 1998; 41:904–910.
Gu D, Reynolds K, Duan Xet al. Prevalence of diabetes and impaired fasting glucose in the chinese adult population: International collaborative study of cardiovascular disease in Asia (InterAsia). Diabetologia. 2003;46:1190–1198.
Ramachandran A, Snehalatha C, Satyavani K et al. Type 2 diabetes in Asian Indian urban children. Diabetes Care 2003; 26:1022–1025.
Malecka-Tendera E, Erhardt E, Molnar D. Type 2 diabetes mellitus in European children and adolescents. Acta Paediatr 2005; 94:543–546.
Schober E, Rami B, Grabert M et al. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 2009; 26:466–473.
Ehtisham S, Hattersley AT, Dunger DB et al. British society for paediatric endocrinology and diabetes clinical trials group. first UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004; 89:526–529.
Hsia Y, Neubert ac, Rani Fet al. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol. 2009; 67:242–249.
Mayor S. Nearly 23,000 people in England aged under 18 have diabetes, survey shows. BMJ 2010; 340:c980.
Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes care 2001; 24:1522–1527.
Mokdad AH, Ford ES, Bowman BA et al. Diabetes trends in the US: 1990–98. Diabetes care 2000; 23:1278–1283.
Aylin P, Williams S, Bottle A. Obesity and type 2 diabetes in children, 1996–7 to 2003–4. BMJ 2005; 19:1167.
Lee JM, Okumura MJ, Freed GL et al. Trends in Hospitalisation for diabetes among children and young adults: United States 1993–2004. Diabetes Care 2007; 30:1–5.
Gungor N, Bacha F, Saad R et al. Youth type 2 diabetes: insulin resistance, β-cell failure or both? Diabetes Care. 2005; 28:638–644.
Gungor N, Arslanian S. Progressive β-cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004; 144:656–659.
Matthews Dr, Cull CA, Stratton IM et al. UKPDS26: sulphonylurea failure in non-insulin dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 1998; 15:297–303.
Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes care 2003; 26:2999–3005.
Rosenbloom AL. Obesity, insulin resistance, beta-cell autoimmunity and the changing clinical epidemiology of childhood diabetes. Diabetes care 2003; 26:2954–2956.
Maldonado Mr, Otiniano ME, Cheema F et al. Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabet Med 2005; 22:1744–1750.
Maldonado Mr, Otiniano ME, Lee Ret al. Characteristics of ketosis-prone diabetes in a multiethnic indigent community. Ethn Dis 2004; 14:243–249.
Mauvais-Jarvis F, Sobngwi E, Porcher Ret al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53:645–653.
Umpierrez GE, Casals MM, Gebhart SP et al. Diabetic ketoacidosis in obese African Americans. Diabetes 1995; 44:790–795.
Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat clin Pract Endocrinol Metab 2008; 4:200–213.
Stone MA, Camosso-Stefinovic J, Wilkinson J et al. Incorrect and incomplete coding and classification of diabetes: a systematic review. Diabet Med 2010; 27:491–497.
Shepherd M, Hattersley AT. ‘I don't feel like a diabetic any more’: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med 2004; 4:144–147.
Eppens MC, Craig ME, Cusumano J et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes care 2006; 29:1300–1306.
Yokoyama H, Okudaira M, Otani T et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients: risk analysis. Diabetes care 1998; 21:1080–1085.
Yoo EG, Choi Ik, Kim DH. Prevalence of microalbuminuria in young patients with type 1 and type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2004; 17:1423–1427.
Yokoyama H, Okudaira M, Otani T et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 1997; 20:844–847.
Okudaira M, Yokoyama H, Otani T et al. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications 2000; 14:281–287.
Henricsson M, Nystrom L, Blohme G et al. The incidence of retinopathy 10 years after diagnosis in young adult with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26:349–354.
Karabouta Z, Barnett S, Shield JP et al. Peripheral neuropathy is an early complication of type 2 diabetes in adolescence. Pediatr Diabetes 2008; 9:110–114.
Paisey RB, Paisey RM, Thomson MP et al. Protection from clinicalperipheral sensory neuropathy in alström syndrome in contrast to early-onset type 2 diabetes. Diabetes care 2009; 32:462–464.
Dean H, Flett B. Natural history of type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes 2002; 51(Suppl 2):A24.
Gungor N, Thompson T, Sutton-Tyrell K et al. Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes care 2005; 28:1219–1221.
Urbina EM, Kimball TR, McCoy CE et al. Youth with obesity and obesity-related type 2 diabetes demonstrate abnormalities in carotid structure and function. Circulation 2009; 119:2913–2919.
Strong JP, Malcolm GT, McMahan CA et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathological Determinants of atherosclerosis in Youth Study. JAMA 1999;281: 727–735.
Song SH, Hardisty CA. Cardiovascular risk profile of early and later onset type 2 diabetes. Practical Diabetes Int 2007; 24:20–24.
Hatunic M, Burns N, Finucane F et al. Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diabetes Vasc Dis Res 2005; 2:73–75.
Benhalima K, Wilmot E, Khunti K et al. Type 2 diabetes in younger adults: clinical characteristics, diabetes-related complications and management of risk factors. Prim care Diabetes 2011; 5:57–62.
Burns N, Finucane F, Hatunic M et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 2007; 50:1500–1508.
Hatunic M, Finucane F, Burns N et al. Vascular inflammatory markers in early-onset obese and type 2 diabetes subjects before and after three months’ aerobic exercise training. Diabetes Vasc Dis res 2007; 4:231–234.
Roper NA, Bilous RW, Kelly WF et al. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001; 322:1389–1393.
Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years—clinical observation from a secondary cohort. QJM 2009; 102:799–806.
Song Sh, Gray Ta, Early intensive cardiovascular risk management in young people with type diabetes. Diabetes Res clin Pract 2011; [Epub ahead of print].
Jeerakathil T, Johnson JA, Simpson EH et al. Short term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 2007; 38:1739–1743.
Guzder RN, Gatling W, Mullee MA et al. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006; 49:49–55.
Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study. Diabetes care 2008; 31:1761–1766.
Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med dy2003; 348:383–393.
CEMACH. Confidential enquiry into maternal and child health. Diabetes in pregnancy: are we providingthe best care? Findings of a national enquiry. England, Wales and Northern Ireland. London: CEMACH, 2007.
Kawahara R, Amemiya T, Yoshino M et al. Dropout of young non-insulin-dependent diabetics from diabetic care. Diabetes res clin Pract 1994; 24:181–185.
Dean H. NIDDM-Y in first Nation children in canada. Clin Pediatr (Phila) 1998; 37:89–96.
Goland R, Lindgren C, Vargas I et al. Enhanced risk for premature vascular disease in adolescent-onset type 2 diabetes. Diabetes 2003; 52(Suppl 1):1749–P.
Baranowski T, Cooper DM, Harrell J et al. Presence of diabetes risk factors in a large US eighth-grade cohort: the STOPP-T2D Prevention Study Group. Diabetes Care 2006; 29:212–217.
Zeitler P, Epstein L, Grey M et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. TODAY Study Group. Pediatr Diabetes 2007; 8:74–87.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Song, S.H. (2013). Emerging Type 2 Diabetes in Young Adults. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5441-0_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5440-3
Online ISBN: 978-1-4614-5441-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)